There is nothing more frustrating than a clinically effective product failing to reach its full potential.

For Marketing and Market Access Directors in mid-sized specialty pharma, the gap between a product’s potential and its performance is often the greatest source of stress. Internally, you face mounting pressure to hit targets and revitalise growth . Externally, and perhaps more importantly, there is the realisation that patients are not benefiting from a treatment that could change their lives, simply because the access or uptake pathway is blocked.

The problem usually isn’t the product it’s the execution in a fragmented NHS.

Strategies that look perfect on paper often fail when they hit the complex reality of the NHS . Internal teams may lack the specific capacity or experience to diagnose the blockage or drive the necessary change . This leaves you stuck second-guessing your next move, holding a plan you cannot effectively execute .

Growth-iQ exists to close the gap between strategy and patient access.

We provide holistic solutions across Sales, Marketing, and Market Access including RWE development and Patient Support Programmes to ensure your value proposition works in the real world, not just in a presentation.

Partnering with us means moving from frustration to momentum:

Diagnose the Drag: Stop guessing why performance is lagging. Within weeks, we identify exactly where the value proposition or pathway is failing .

Implementation, Not Just Theory: We don’t just recommend a fix and walk away. We support the execution, ensuring your strategy is actually adopted in NHS conversations and decision-making .

Patient & Commercial Impact: By unblocking the pathway, we help you meet internal growth expectations while ensuring patients finally get access to the treatment they need.

Risk-Free Agility: We work on a stepped engagement model. You retain full control and only pay for work completed and milestones met allowing you to revitalise the brand without

Growth-iQ Group

Org chart

Teams

Offices